Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ENROLLING BY INVITATION
NCT06575010
PHASE4

Exparel v Dexamethasone in RCR

Sponsor: Rothman Institute Orthopaedics

View on ClinicalTrials.gov

Summary

Effective and safe control of pain after shoulder surgery is an important component of the post-surgical process. Patients who are comfortable in the early period after surgery are more satisfied with their experience and are better able to participate in rehabilitation exercises during their stay in the hospital. As surgeons and health care systems in the United States find themselves in the middle of an opioid epidemic, it is necessary to discover different options to provide patients pain relief that are both effective and safe in an effort to decrease the amount of pain medication used.

Official title: Single-Shot Liposomal Bupivacaine vs. Liposomal Bupivacaine Combined With Dexamethasone Following Arthroscopic Rotator Cuff Repair: A Prospective Randomized Controlled Trial

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

126

Start Date

2024-08-26

Completion Date

2025-08-30

Last Updated

2024-08-28

Healthy Volunteers

Yes

Interventions

DRUG

Liposomal bupivacaine

20 mL Liposomal bupivacaine (Exparel) will be given in the shoulder block prior to surgery

DRUG

Bupivacaine Hcl 0.5% Inj

0.75% bupivacaine will be given in the shoulder block prior to surgery

DRUG

Dexamethasone

10 mg Dexamethasone will be given in the shoulder block prior to surgery

Locations (1)

Rothman Orthopaedic Institute

Philadelphia, Pennsylvania, United States